olfactory receptor family 5 subfamily AW member 1 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR5AW1P profile across patient tissues and cancer cell-line models. OR5AW1P expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in LIHC. Among the 18 cancer types available for tumor–normal comparison, OR5AW1P is differentially expressed in 6, with the highest sampling consensus in HNSC. Additionally, OR5AW1P RNA expression shows 11,233 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight LIHC, HNSC, and THYM as cancer lineages where OR5AW1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR5AW1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR5AW1P survival associations across molecular data types. OR5AW1P RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR5AW1P RNA expression–survival associations across cancer types. High OR5AW1P expression shows unfavorable associations in READ, KIRC, HNSC and LUAD, but favorable associations in LIHC and UCS. The LIHC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .003). Together, the overview and detailed table identify LIHC as the clearest survival context for OR5AW1P RNA expression.
This table summarizes OR5AW1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for OR5AW1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR5AW1P shows higher tumor expression in HNSC, BLCA, LUSC, STAD, LUAD and LIHC. The HNSC box plot shows higher OR5AW1P RNA expression in tumor versus normal tissue (log2 FC = +0.039, t-test p < 0.001).
This table shows molecular features associated with OR5AW1P in patient tissues and cancer cell lines. In patient samples, OR5AW1P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
